Discover

XTNT
Xtant Medical Holdings, Inc.
0.42
3000 x undefined
300 x 0.44
bid
ask
-
0.00
0.24%
1650 @ 04:00 PM
0.42 +0.00 (0.00%)
Ytd-46.15%
1y-41.67%
0.42
day range
0.44
0.40
52 week range
0.95
Open0.43Prev Close0.42Low0.42High0.44Mkt Cap58.91M
Vol55.86KAvg Vol138.96KEPS0.01P/E42.00Forward P/E-13.43
Beta0.39Short Ratio6.92Inst. Own65.12%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg0.48200-d Avg0.611yr Est2.25
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-122024-090-0.04N/AN/A
2024-08-082024-060-0.03N/AN/A
2024-05-152024-030-0.03N/AN/A
2024-04-012023-120-0.03N/AN/A
2023-11-092023-0900.07N/AN/A
2023-08-012023-060-0.02N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-05-16BTIGUpgradeBuyBuy
2023-12-05BTIGUpgradeBuy
2023-07-11Craig-HallumUpgradeBuyBuy
2023-04-26Craig-HallumUpgradeBuy
2019-05-17Maxim GroupDowngradeBuyHold
2016-12-08Maxim GroupUpgradeBuy
Profile
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.
Insider Holder
DateNameRelationQuantityDescription
2024-08-14BAKEWELL JOHN KDirector755.89KStock Award(Grant)
2024-08-14BEESON JONN R.Director1.37MStock Award(Grant)
2024-04-02BRANDT KEVIN DOfficer1.00MStock Award(Grant)
2024-04-02BROWNE SEAN E.Chief Executive Officer2.31MStock Award(Grant)
2024-08-14MCNAMARA ROBERT EDirector754.15KStock Award(Grant)
2024-08-14MITCHELL-KELLER LORI DDirector353.12KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Orbimed Advisors LLC.73.11M29.47M52.60%
2024-09-29Nantahala Capital Management, LLC11.39M4.59M8.20%
2024-09-29Altium Capital Management, LP7.42M2.99M5.33%
2024-09-29Vanguard Group Inc2.15M866.82K1.55%
2024-09-29Juniper Investment Company, LLC1.32M531.53K0.95%
2024-09-29Renaissance Technologies, LLC694.21K279.77K0.50%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Total Stock Market Index Fund1.43M576.87K1.03%
2024-09-29Vanguard Extended Market Index Fund719.48K289.95K0.52%
2024-10-30Fidelity Extended Market Index Fund292.92K118.04K0.21%
2024-09-29Bridgeway Funds Inc-Ultra Small Company Market Fund279.00K112.44K0.20%
2024-10-30Fidelity Total Market Index Fund114.33K46.08K0.08%
2024-10-30Fidelity Series Total Market Index Fund69.35K27.95K0.05%
Split
SplitDate
1 : 122018-02-14
1 : 102014-07-28
0.5 : 12010-07-02